Altimmune is a clinical stage immunotherapeutics company focused on the discovery and development of products to stimulate immune responses for the prevention and treatment of diseases. The company's product candidates include: HepTcell, an immunotherapeutic for patients infected with the hepatitis B virus; ALT-702, a tumor immunostimulant designed to elicit or improve immune responses to cancers; NasoVAX, an intranasally administered recombinant influenza vaccine which stimulates an immune response; NasoShield, an anthrax vaccine designed to provide protection after a single intranasal administration; and SparVax-L, a recombinant protein-based anthrax vaccine designed to require fewer doses.

Limoneira is an agribusiness and real estate development company. The company's operations consist of fruit production, sales and marketing, rental operations, real estate development and capital investment activities. The company has the following business divisions: agribusiness, which is comprised of the following segment, including fresh lemons, lemon packing, avocados and other agribusiness, as well as its farming, harvesting, lemon packing and lemon sales operations; rental operations, which includes the company's residential and commercial rentals, leased land operations and organic recycling; and real estate development, which includes the company's real estate development operations.

TriplePoint Venture Growth BDC is an externally managed, closed-end, non-diversified management investment company. The company's investment objective is provide stockholders with current income and, to a lesser extent, capital appreciation by primarily lending with warrant investments to venture growth stage companies focused in technology, life sciences and other industries that are backed by TriplePoint Capital LLC's select group of venture capital investors.